Ipratropium Bromide (Nephron Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Ipratropium Bromide drug offered from Nephron Pharmaceuticals Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Nephron Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | Ipratropium Bromide |
SUBSTANCE NAME: | IPRATROPIUM BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2001-09-27 |
END MARKETING DATE: | 0000-00-00 |
Ipratropium Bromide HUMAN PRESCRIPTION DRUG Details:
Item Description | Ipratropium Bromide from Nephron Pharmaceuticals Corporation |
LABELER NAME: | Nephron Pharmaceuticals Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/2.5mL) |
START MARKETING DATE: | 2001-09-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0487-9801_97e130d5-02ce-4acb-b2bc-71877751a29c |
PRODUCT NDC: | 0487-9801 |
APPLICATION NUMBER: | ANDA075562 |
Other IPRATROPIUM BROMIDE Pharmaceutical Manufacturers / Labelers: